PPARGC1A and metastatic melanoma: Previous study showed that PGC1-α (PPARGC1A) suppressed melanoma metastasis, and that high PGC1α expression is associated with worse prognosis in metastatic melanomas (31, 32), and that high GARBD expression is associated with poor survival (33).